Select your goals and experience level. We'll match you with pre-built, evidence-informed peptide stacks, including dosing, timing, and estimated costs.
Select one or more. We'll find stacks that match.
We'll only show stacks at or below your comfort level.
Showing beginner stacks.
Select at least one goal above to see matching stacks.
The builder does not generate a protocol for you. It filters a fixed editorial set of ten documented stacks against two inputs: the goals you select, and the experience level you set.
Each card lists the compounds with the dose range reported in the source protocol, the cycle length, an indicative monthly cost, and the number of compounds involved. Dose ranges are ranges for a reason — they reflect the spread across the literature and community reports, not a recommendation to start at the top of the range.
Only a few of the compounds referenced here are approved for human use — semaglutide and tesamorelin among them. The rest, including BPC-157, TB-500, DSIP, KPV, PT-141, Pinealon, AOD-9604, MOTS-c, Semax, Selank, Dihexa, Thymosin Alpha-1 and LL-37, are research compounds. Their legal status varies by country and none should be treated as a consumer product.
Our mission is to make peptide research clear, credible, and usable for people who refuse to rely on hype.